eyes – Scalper1

Second Sight Medical Sees ‘Major Milestone’

Shares of Second Sight Medical Products (EYES) jumped Wednesday as the maker of implantable visual prosthetics reported successful test results in an animal study. Second Sight announced the first successful test of a mechanical model of its Orion I Visual Cortical Prosthesis in a preclinical animal study. The study is to evaluate the device’s fit, form, stability and biocompatibility. Second Sight develops, makes and markets implantable visual

IPO Stock Watch: Second Sight Medical Sees Strong IPO

Medical device company Second Sight Medical Products (EYES) had to like the view of its initial public offering Wednesday. The company, which makes implantable visual prosthetics, raised $32 million in the IPO by offering 3.5 million shares at 9, as expected. The stock was near 21, up 133%, in afternoon trading on the stock market today. Second Sight develops, makes and markets implantable visual prosthetics to restore some functional vision to